Core Viewpoint - Zenas BioPharma is facing a class action lawsuit due to allegations of misleading information in its IPO registration statement, which has resulted in significant financial losses for investors [1][3][4]. Group 1: Company Overview - Zenas BioPharma is a clinical-stage biopharmaceutical company focused on developing and commercializing immunology-based therapies [3]. Group 2: IPO Details - The company sold over 13 million shares at a price of $17.00 each during its IPO [3]. - The IPO registration statement claimed that Zenas BioPharma could fund its operations for 24 months using existing cash and anticipated IPO proceeds [3]. Group 3: Allegations and Financial Impact - The class action lawsuit alleges that the IPO documents were materially false and misleading, particularly regarding the funding timeline [3]. - On November 12, 2024, Zenas BioPharma disclosed in its quarterly report that it could only fund operations for 12 months, contradicting the earlier statement [4]. - As of April 15, 2025, the stock price had dropped to $8.72, representing a decline of 48.7% from the IPO price [4].

Dynavax is Already Delivering Significant Long Term Stockholder Value Through Execution of Current Strategy Overseen by Board; Deep Track's Inferior Short-Term Plan and Nominees are Not in the Best Interests of All Stockholders Glass Lewis' Recommendation Recognizes the Significant Stockholder Value Creation and Differentiated Capital Return Overseen by the Dynavax BoardReiterates ISS and Egan Jones Recommendations that Stockholders Support ALL Dynavax Nominees and Deep Track Board Representation is Not War ...

Core Viewpoint - Ibotta, Inc. is facing a class action lawsuit due to alleged misleading statements in its registration statement related to its IPO on April 18, 2024, particularly concerning its contract with Kroger [1][3][4] Group 1: Legal Action - The Portnoy Law Firm is advising Ibotta investors about a class action lawsuit for those who purchased securities linked to the company's IPO [1] - Investors have until June 16, 2025, to file a lead plaintiff motion [1] Group 2: Allegations - The complaint claims that the registration statement failed to disclose the at-will nature of Ibotta's contract with Kroger, which could be terminated at any time without notice [3] - The registration statement provided details about Ibotta's contract with Walmart but omitted warnings regarding the risks associated with the Kroger agreement [3] Group 3: Financial Impact - Due to the alleged wrongful acts and omissions, Ibotta's stock price experienced a sharp decline, resulting in substantial losses for the plaintiff and other class members [4]

ATLANTA, June 04, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) complied with federal securities laws. On June 4, 2025, Morpheus Research published a report alleging that Abacus’s returns “are primarily manufactured by the systematic overvaluation of its assets through an opaque ‘mark to model’ accounting scheme that closely mirrors past blow-ups in the life settlements industry.” Following this report, the pri ...

HealthEquity, Inc. HQY posted better-than-expected first-quarter results after Tuesday’s closing bell.HealthEquity reported quarterly earnings of 97 cents per share, which beat the consensus estimate of 88 cents. Quarterly revenue came in at $330.8 million, beating the Street estimate of $321.17 million."The HealthEquity team started fiscal 2026 with a strong first quarter that included record quarterly revenue, record Adjusted EBITDA and increased guidance for the year," said Scott Cutler, CEO of HealthEqu ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BigBear.ai Holdings, Inc. ("BigBear " or the "Company") (NYSE: BBAI) investors of a class action representing investors that bought securities between March 31, 2022 and March 25, 2025, inclusive (the "Class Period"). BigBear investors have until June 10, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley ...

SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen securities between July 27, 2023 and May 15, 2025. The lawsuit comes after investors saw the price of their shares in UroGen Pharma Ltd. (NASDAQ: URGN) crash on May 16, 2025 as a result of the FDA’s publication of a briefing document a few days before an upcoming ...

Group 1 - The article discusses the author's journey into investing, starting in high school in 2011, focusing on REITs, preferred stocks, and high-yield bonds, indicating a long-standing interest in markets and the economy [1] - The author has recently adopted a strategy that combines long stock positions with covered calls and cash secured puts, emphasizing a fundamental long-term investment approach [1] - The author primarily covers REITs and financials on Seeking Alpha, with occasional articles on ETFs and other stocks influenced by macro trade ideas [1]

A prolonged FCC review against a backdrop of President Donald Trump’s lawsuit is fueling speculation that a Paramount–Skydance marriage may be heading for the rocks.    In a note Wednesday, analyst Rich Greenfield of LightShed Partners voiced what others have started to wonder, saying he’s “increasingly concerned the deal could collapse as Paramount is paralyzed by legal fears surrounding the pending President Trump–CBS 60 Minutes lawsuit.” The proposed merger announced last summer carried several automat ...

Group 1: Apple App Store Performance - Apple's App Store revenue for May increased by 4.9% month-over-month, surpassing the historical average of 2.3% for this period, leading to a year-over-year revenue growth of 13.0% in May compared to 11.8% in April [1] - App Store downloads rose by 2.0% month-over-month in May, contrasting with a decline of 4.6% in April, and showed a year-over-year increase of 3.1% in May, down from 5.8% in April [3] Group 2: Analyst Insights and Forecasts - Analyst Samik Chatterjee maintains an Overweight rating on Apple, indicating confidence in the company's performance despite the lack of official guidance for Services revenue growth [1][2] - Monthly revenue trends for the App Store are expected to support low-double-digit year-over-year growth in Services, aligning with Chatterjee's forecasts [2] Group 3: Smartphone Market Concerns - Counterpoint Research has revised global smartphone shipment growth expectations for 2025 down to 1.9% from 4.2%, attributing this to tariff-related uncertainties [4] - IDC forecasts U.S. smartphone shipment growth to be 1.9% in 2025, a decrease from 3.3% in 2017, also due to tariff-related price increases [5] - Deepwater Research's Gene Munster suggests Apple has about two years to refine its AI strategy, which will necessitate increased investments [5]